Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$3.13M Buy
17,000
+2,550
+18% +$457K 1.36% 21
2019
Q1
$2.75M Hold
14,450
1.17% 32
2018
Q4
$2.81M Hold
14,450
1.35% 14
2018
Q3
$3M Hold
14,450
1.34% 16
2018
Q2
$2.67M Hold
14,450
1.27% 29
2018
Q1
$2.46M Hold
14,450
1.15% 38
2017
Q4
$2.51M Buy
14,450
+950
+7% +$168K 1% 44
2017
Q3
$2.52M Hold
13,500
1.33% 24
2017
Q2
$2.33M Hold
13,500
1.23% 29
2017
Q1
$2.21M Hold
13,500
1.16% 32
2016
Q4
$1.97M Buy
13,500
+1,400
+12% +$211K 0.93% 37
2016
Q3
$2.02M Hold
12,100
1.24% 15
2016
Q2
$1.84M Hold
12,100
1.04% 23
2016
Q1
$1.81M Hold
12,100
0.94% 29
2015
Q4
$1.96M Hold
12,100
1.17% 20
2015
Q3
$1.67M Hold
12,100
1.08% 32
2015
Q2
$1.86M Hold
12,100
1% 37
2015
Q1
$1.93M Hold
12,100
0.96% 37
2014
Q4
$1.93M Hold
12,100
1% 32
2014
Q3
$1.7M Hold
12,100
0.94% 41
2014
Q2
$1.43M Hold
12,100
0.92% 57
2014
Q1
$1.49M Hold
12,100
0.69% 73
2013
Q4
$1.38M Hold
12,100
0.65% 81
2013
Q3
$1.35M Hold
12,100
0.87% 39
2013
Q2
$1.19M Buy
+12,100
New +$1.26M 0.8% 49

Other funds holding AMGN

Midas Management's AMGN Position: Q2 2019 in Review

Midas Management increased its Amgen (AMGN) stake by 18% in Q2 2019, buying an estimated $457K and bringing the position to 17,000 shares worth $3.13M. The position accounts for 1.36% of the portfolio, ranked #21.

Midas Management first reported a position in AMGN in Q2 2013 and has held it in 25 quarters since. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Midas Management held 17,000 shares of Amgen worth $3.13M as of Q2 2019.
  • Midas Management bought 2,550 Amgen shares in Q2 2019, an estimated $457K.
  • Amgen made up 1.36% of Midas Management's portfolio in Q2 2019, its #21 holding.
  • Midas Management first reported a position in Amgen in Q2 2013 and has held it in 25 quarters since.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Midas Management's 13F filing for Q2 2019, filed 9 Jul 2019.